查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599296

病毒载体製造市场：按类型、疾病和应用分类 - 2025-2030 年全球预测

Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年病毒载体製造市场价值为10.5亿美元，预计到2024年将达到12.5亿美元，复合年增长率为19.11%，到2030年将达到35.9亿美元。

病毒载体製造在基因治疗、疫苗生产和其他新型医学应用领域中发挥重要作用。这些载体充当将遗传物质运送到细胞中的递送载体，这是纠正遗传缺陷或诱导所需细胞反应的重要过程。对病毒载体的需求源于它们有效转导多种细胞类型的能力，这使得它们对于开发先进治疗方法和疫苗至关重要。应用范围从解决罕见遗传疾病到广泛的疫苗生产，最引人注目的是病毒载体平台在 COVID-19 疫苗开发中的成功。最终用途包括製药公司、生物技术公司、研究机构和受託製造厂商，它们在利用这些技术方面进行了大量投资。基因疗法的核准不断增加、遗传疾病和慢性病患病率上升以及对创新治疗解决方案的需求不断增加，推动了病毒载体製造的市场成长。此外，扩大研究合作和增加对生物技术领域的投资正在刺激研究和开发，提供利润丰厚的机会。然而，市场面临一些挑战，例如高製造成本、复杂的监管环境和扩充性问题，阻碍了潜力的充分发挥。创新持续专注于提高载体生产力、降低成本和提高交付效率，研究重点是开发新型载体类型和可扩展的生产技术。市场的本质是激进且快速变化的，需要相关人员的敏捷性和远见来保持竞争优势。业务成长的机会在于简化生产机制和解决定价问题，从而显着扩大消费者获得这些突破性治疗方法。透过专注于伙伴关係和投资尖端研究，我们还可以加速市场进入和扩张。组织应专注于优化流程效率和扩大产能，以解决与成本相关的限制并巩固其市场地位。

主要市场统计
基准年[2023] 10.5亿美元
预测年份 [2024] 12.5亿美元
预测年份 [2030] 35.9亿美元
复合年增长率（%） 19.11%

市场动态：针对快速发展的病毒载体製造市场所揭示的关键市场见解

供需的动态交互作用正在改变病毒载体製造市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 癌症、代谢性疾病和心臟病等疾病的盛行率增加
    • 基因疗法开发的成长
    • 基于病毒载体的基因治疗的临床试验註册人数增加
  • 市场限制因素
    • 病毒载体储存期限限制
  • 市场机会
    • 对产量优化的浓厚兴趣
    • 病毒载体生产的创新
  • 市场挑战
    • 病毒载体生产的严格监管指导

波特的五力：驾驭病毒载体製造市场的策略工具

波特的五力框架是了解病毒载体製造市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解病毒载体製造市场的外部影响

外部宏观环境因素在塑造病毒载体製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解病毒载体製造市场的竞争状况

对病毒载体製造市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵病毒载体製造市场供应商绩效评估

FPNV定位矩阵是评估病毒载体製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了病毒载体製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对病毒载体製造市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症、代谢性疾病和心臟缺陷等疾病的发生率增加
      • 基因疗法开发的成长
      • 病毒载体介导的基因治疗临床试验的招募人数增加
    • 抑制因素
      • 病毒载体的保质期有限
    • 机会
      • 专注于收益优化
      • 病毒载体生产的创新
    • 任务
      • 病毒载体生产的严格监管指导
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章病毒载体製造市场：依类型

  • 腺结合病毒载体
  • 腺病毒载体
  • 慢病毒载体
  • 逆转录病毒载体

第七章病毒载体製造市场：依疾病分类

  • 癌症
  • 遗传疾病
  • 感染疾病

第八章病毒载体製造市场：依应用分类

  • 基因治疗
  • 疫苗学

第九章美洲病毒载体製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区病毒载体製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的病毒载体製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ABL Inc.
  • Beckman Coulter, Inc.
  • Biovian Oy
  • Charles River Laboratories International, Inc.
  • Cytiva
  • Finvector
  • FUJIFILM Diosynth Biotechnologies USA, Inc.
  • Genezen Laboratories, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Sanofi SA
  • Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • uniQure NV
Product Code: MRR-FD3F12D54086

The Viral Vector Manufacturing Market was valued at USD 1.05 billion in 2023, expected to reach USD 1.25 billion in 2024, and is projected to grow at a CAGR of 19.11%, to USD 3.59 billion by 2030.

Viral vector manufacturing plays a crucial role in the field of gene therapy, vaccine production, and other novel medical applications. These vectors serve as delivery vehicles to transport genetic material into cells, a process critical for correcting genetic disorders or instigating a desired cellular response. The necessity of viral vectors stems from their ability to effectively transduce a broad spectrum of cell types, making them indispensable in the development of advanced therapies and vaccines. Their application spans from addressing rare genetic disorders to broad-based vaccine production, demonstrated most prominently by the success of viral vector platforms in COVID-19 vaccine development. The end-use scope includes pharmaceutical and biotechnology companies, research institutions, and contract manufacturing organizations that are deeply invested in harnessing these technologies. Market growth for viral vector manufacturing is driven by increasing approvals of gene therapies and rising incidences of genetic and chronic diseases, which heighten demand for innovative therapeutic solutions. Additionally, expanding research collaborations and escalating investments in the biotech sector fuel development, presenting lucrative opportunities. However, the market faces several challenges, such as high manufacturing costs, complex regulatory landscapes, and scalability issues, hindering full potential realization. Innovation continues to focus on enhancing vector productivity, reducing costs, and improving delivery efficiency, with research gravitating towards developing novel vector types and scalable production technologies. The market's nature is aggressive and rapidly changing, demanding agility and foresight from stakeholders to maintain competitive advantage. Opportunities for business growth lie in streamlining production mechanisms and addressing affordability issues, which could significantly expand consumer access to these groundbreaking therapies. Emphasizing partnerships and investment in cutting-edge research can also facilitate market entry and expansion. Organizations should focus on optimizing process efficiencies and scaling up production capabilities to tackle cost-related constraints and fortify market position.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.25 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 19.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viral Vector Manufacturing Market

The Viral Vector Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of disease such as cancer, metabolic diseases, heart defects
    • Growth in development of gene therapy
    • Rise in registration of clinical trials for viral vector-mediated gene therapy
  • Market Restraints
    • Limited shelf-life of viral vector
  • Market Opportunities
    • High focus on yield optimization
    • Technology innovation in viral vector manufacturing
  • Market Challenges
    • Strict regulatory guidance for viral vector manufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Viral Vector Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viral Vector Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viral Vector Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viral Vector Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viral Vector Manufacturing Market

A detailed market share analysis in the Viral Vector Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viral Vector Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viral Vector Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Viral Vector Manufacturing Market

A strategic analysis of the Viral Vector Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Viral Vector Manufacturing Market, highlighting leading vendors and their innovative profiles. These include ABL Inc., Beckman Coulter, Inc., Biovian Oy, Charles River Laboratories International, Inc., Cytiva, Finvector, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Genezen Laboratories, Inc., Lonza Group Ltd., Merck KGaA, Novartis AG, Sanofi SA, Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and uniQure N.V..

Market Segmentation & Coverage

This research report categorizes the Viral Vector Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors, and Retroviral Vectors.
  • Based on Disease, market is studied across Cancer, Genetic Disorders, and Infectious Diseases.
  • Based on Application, market is studied across Gene Therapy and Vaccinology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of disease such as cancer, metabolic diseases, heart defects
      • 5.1.1.2. Growth in development of gene therapy
      • 5.1.1.3. Rise in registration of clinical trials for viral vector-mediated gene therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Limited shelf-life of viral vector
    • 5.1.3. Opportunities
      • 5.1.3.1. High focus on yield optimization
      • 5.1.3.2. Technology innovation in viral vector manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory guidance for viral vector manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Viral Vector Manufacturing Market, by Type

  • 6.1. Introduction
  • 6.2. Adeno-associated Viral Vectors
  • 6.3. Adenoviral Vectors
  • 6.4. Lentiviral Vectors
  • 6.5. Retroviral Vectors

7. Viral Vector Manufacturing Market, by Disease

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Genetic Disorders
  • 7.4. Infectious Diseases

8. Viral Vector Manufacturing Market, by Application

  • 8.1. Introduction
  • 8.2. Gene Therapy
  • 8.3. Vaccinology

9. Americas Viral Vector Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Viral Vector Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Viral Vector Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL Inc.
  • 2. Beckman Coulter, Inc.
  • 3. Biovian Oy
  • 4. Charles River Laboratories International, Inc.
  • 5. Cytiva
  • 6. Finvector
  • 7. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • 8. Genezen Laboratories, Inc.
  • 9. Lonza Group Ltd.
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Sanofi SA
  • 13. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • 14. Thermo Fisher Scientific Inc.
  • 15. uniQure N.V.

LIST OF FIGURES

  • FIGURE 1. VIRAL VECTOR MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. VIRAL VECTOR MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRAL VECTOR MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRAL VECTOR MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023